Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Visser

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Plos One|April 29, 2022
Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitroMarion M Malenge, Astri Fjelde Maaland, Ada Repetto-Llamazares, et al.
British Journal of Haematology|February 16, 2008
Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22Marijke Niens, Lydia Visser, Ilja M Nolte, et al.
British Journal of Haematology|February 28, 2020
Interim thymus and activation regulated chemokine versus interim <sup>18</sup> F-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluationWouter J Plattel, Lydia Visser, Arjan Diepstra, et al.
European Radiology|April 28, 2019
Tumour necrosis as assessed with <sup>18</sup>F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangementsXaver U Kahle, Menno Hovingh, Walter Noordzij, et al.
Oncotarget|October 27, 2015
Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphomaIzabella Slezak-Prochazka, Joost Kluiver, Debora de Jong, et al.
Oncoimmunology|February 3, 2022
CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphomaJohanna Veldman, Jessica Rodrigues Plaça, Lauren Chong, et al.
British Journal of Haematology|December 15, 2005
High expression of calcium-binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphomaRenata Rust, Lydia Visser, Judith van der Leij, et al.
International Journal of Molecular Sciences|July 27, 2022
Cytochrome P450 27C1 Level Dictates Lung Cancer Tumorigenicity and Sensitivity towards Multiple Anticancer Agents and Its Potential Interplay with the IGF-1R/Akt/p53 Signaling PathwayHai-Ying Mo, Qi-Yao Wei, Qiu-Hua Zhong, et al.
Plos One|March 24, 2017
HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patientsLuke B Fletcher, Rianne N Veenstra, Eric Y Loo, et al.
Plos One|January 12, 2016
Proteomics Based Identification of Proteins with Deregulated Expression in B Cell LymphomasRui Wu, Marcel Nijland, Bea Rutgers, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Plos One|April 29, 2022
Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitroMarion M Malenge, Astri Fjelde Maaland, Ada Repetto-Llamazares, et al.
British Journal of Haematology|February 16, 2008
Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22Marijke Niens, Lydia Visser, Ilja M Nolte, et al.
British Journal of Haematology|February 28, 2020
Interim thymus and activation regulated chemokine versus interim <sup>18</sup> F-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluationWouter J Plattel, Lydia Visser, Arjan Diepstra, et al.
European Radiology|April 28, 2019
Tumour necrosis as assessed with <sup>18</sup>F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangementsXaver U Kahle, Menno Hovingh, Walter Noordzij, et al.
Oncotarget|October 27, 2015
Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphomaIzabella Slezak-Prochazka, Joost Kluiver, Debora de Jong, et al.
Oncoimmunology|February 3, 2022
CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphomaJohanna Veldman, Jessica Rodrigues Plaça, Lauren Chong, et al.
British Journal of Haematology|December 15, 2005
High expression of calcium-binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphomaRenata Rust, Lydia Visser, Judith van der Leij, et al.
International Journal of Molecular Sciences|July 27, 2022
Cytochrome P450 27C1 Level Dictates Lung Cancer Tumorigenicity and Sensitivity towards Multiple Anticancer Agents and Its Potential Interplay with the IGF-1R/Akt/p53 Signaling PathwayHai-Ying Mo, Qi-Yao Wei, Qiu-Hua Zhong, et al.
Plos One|March 24, 2017
HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patientsLuke B Fletcher, Rianne N Veenstra, Eric Y Loo, et al.
Plos One|January 12, 2016
Proteomics Based Identification of Proteins with Deregulated Expression in B Cell LymphomasRui Wu, Marcel Nijland, Bea Rutgers, et al.
Pageof 8